
From PD-L1 downregulation to biomarker-driven immunotherapy design: advancing translational application of SALL4-targeted PEN-FFW in breast cancer
<a href="https://news.google.com/rss/articles/CBMibEFVX3lxTFBIQVFiakNvT0RiSTAydXlhYXluM2RtcDRUdGF2R1NmOWdTNWVENWRjSkVGa1RvSTJhc1lYTmlqVS1GMjNwbWRkaTJONXVYUDJHcGJTcFlhSEM4WTMzYVp1T1VfcTNZYmxjV3I4LQ?oc=5" target="_blank">From PD-L1 downregulation to biomarker-driven immunotherapy design: advancing translational application of SALL4-targeted PEN-FFW in breast cancer</a>&nbsp;&nbsp;<font color="#6f6f6f">Springer Nature Link</font>
